Severe course of HIV-related Kaposi’s sarcoma with cutaneous, visceral and oral manifestations in a late-presenting patient

Szymon Barczak; Barbara Badura; Agnieszka Lembas; Tomasz Mikuła; Alicja Wiercińska-Drapało

doi:10.56782/pps.188

Data publikacji : 2024-05-08

Tom 22 Nr 2 (2024)

Severe course of HIV-related Kaposi’s sarcoma with cutaneous, visceral and oral manifestations in a late-presenting patient

Szymon Barczak

Barbara Badura

Agnieszka Lembas

Tomasz Mikuła

Alicja Wiercińska-Drapało

DOI: https://doi.org/10.56782/pps.188

Abstrakt

Kaposi’s sarcoma is a soft tissue tumor caused by human herpesvirus 8 (HHV-8). One of its forms is associated with human immunodeficiency virus (HIV) and is characterized by involvement of the skin and internal organs. We present a case of a 42-year-old male diagnosed with acquired immunodeficiency syndrome (AIDS) and disseminated Kaposi’s sarcoma with cutaneous, oral and visceral manifestations. During the months of hospitalization the patient suffered from neutropenic fever, gastrointestinal bleedings and required multiple blood transfusions. The patient was started on antiretroviral treatment followed by chemotherapy with paclitaxel. The skin lesions regressed, the patient gained weight and there was an improvement in performance status. This case demonstrates how severe HIV-related Kaposi’s sarcoma can be and the effectiveness of antiretroviral treatment combined with chemotherapy in combating the disease. The authors believe that great effort must be made to prevent new HIV infections and all the negative implications that may follow.

Inne teksty tego samego autora

Olga Grelewicz, Gabriela Kulbacka, Tomasz Mikuła, Alicja Wiercińska-Drapało, Does testosterone intake affect diagnosing primary HIV infection? , Prospects in Pharmaceutical Sciences: Tom 21 Nr 1 (2023)
Agnieszka Lembas, Andrzej Załęski, Tomasz Mikuła, Joanna Jabłońska, Szymon Barczak, Barbara Badura, Alicja Wiercińska-Drapało, Differences in the course of hepatocellular carcinoma depending on the DAA treatment , Prospects in Pharmaceutical Sciences: Tom 22 Nr 3 (2024)

Podobne artykuły

Paweł Żero, Maria Niemyjska, Magdalena Rasztawicka, Dorota Maciejewska, CHOROBA NOWOTWOROWA PIERSI I NOWE ZWIĄZKI O AKTYWNOŚCI PRZECIWNOWOTWOROWEJ , Prospects in Pharmaceutical Sciences: Tom 3 Nr 2 (2005)
Ewelina Flegiel, english English, English English, English English, English English, English English, English English, English English, English English, English English, English , Prospects in Pharmaceutical Sciences: Tom 22 Nr 4 (2024)

<< < 1 2

Możesz również Rozpocznij zaawansowane wyszukiwanie podobieństw dla tego artykułu.

Szczegóły

Bibliografia

Statystyki

Autorzy

Pobierz pliki

PDF (English)

Zasady cytowania

Barczak, S., Badura, B., Lembas, A., Mikuła, T., & Wiercińska-Drapało, A. (2024). Severe course of HIV-related Kaposi’s sarcoma with cutaneous, visceral and oral manifestations in a late-presenting patient. Prospects in Pharmaceutical Sciences, 22(2), 26–29. https://doi.org/10.56782/pps.188

Wskaźniki altmetryczne

Cited by / Share

Licencja

Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa 4.0 Międzynarodowe.

Bibliografia

Bishop, BN; Lynch, D.T. Kaposi Sarcoma. StatPearls. Published online June 5, 2023. Accessed September 5, 2023. https://www.ncbi.nlm.nih.gov/books/NBK534839/

Tounouga, D.N., Kouotou, E.A.; Nansseu, J.R.; Zoung-Kanyi Bissek, A.C. Epidemiological and Clinical Patterns of Kaposi Sarcoma: A 16-Year Retrospective Cross-Sectional Study from Yaoundé, Cameroon. Dermatology 2018, 234(5-6), 226-228. doi:10.1159/000492175 DOI: https://doi.org/10.1159/000492175

Thieringer, F.M.; Cede, J.; Glatz, K.; Roehling, S.; Stoeckle, M.; Leiggener, C.S. Oral Kaposi’s Sarcoma: A Case Report and Literature Review on Treatment Management. Craniomaxillofac. Trauma Reconstr. 2021, 6. doi:10.1177/24727512211036328 DOI: https://doi.org/10.1177/24727512211036328

Hoffmann, C.; Sabranski, M.; Esser S. HIV-Associated Kaposi’s Sarcoma. Oncol. Res. Treat. 2017, 40(3), 94-98. doi:10.1159/000455971 DOI: https://doi.org/10.1159/000455971

Azam, F.; Latif, M.F.; Farooq, A.; et al. Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals. Case Rep. Oncol. 2019, 12(3), 728-736. doi:10.1159/000503095 DOI: https://doi.org/10.1159/000503095

Miranda, M.N.S.; Pingarilho, M.; Pimentel, V.; et al. Determinants of HIV-1 Late Presentation in Patients Followed in Europe. Pathogens 2021, 10(7), Art. No: 835. doi:10.3390/PATHOGENS10070835 DOI: https://doi.org/10.3390/pathogens10070835

The Late Presentation Working Groups in EuroSIDA and COHER. Estimating the burden of HIV late presentation and its attributable morbidity and mortality across Europe 2010-2016. BMC Infect. Dis. 2020, 20(1), Art. No: 728. https://doi.org/10.1186/s12879-020-05261-7 DOI: https://doi.org/10.1186/s12879-020-05261-7

Liu, Z.; Fang, Q.; Zuo, J.; Minhas, V.; Wood, C.; Zhang, T. The world-wide incidence of Kaposi’s sarcoma in the HIV/AIDS era. HIV Med. 2018, 19(5), 355-364. doi:10.1111/HIV.12584 DOI: https://doi.org/10.1111/hiv.12584

Lemlich, G.; Schwam, L.; Lebwohl, M. Kaposi’s sarcoma and acquired immunodeficiency syndrome. Postmortem findings in twenty-four cases. J. Am. Acad. Dermatol. 1987, 16 (2 Pt 1), 319-325. doi:10.1016/S0190-9622(87)70043-7 DOI: https://doi.org/10.1016/S0190-9622(87)70043-7

DiNenno, E.A., Prejean, J.; Irwin, K.; et al. Recommendations for HIV Screening of Gay, Bisexual, and Other Men Who Have Sex with Men - United States, 2017. MMWR Morb. Mortal. Wkly Rep. 2017, 66(31), 830-832. doi:10.15585/MMWR.MM6631A3 DOI: https://doi.org/10.15585/mmwr.mm6631a3

Wurm, M.; Neumann, A.; Wasem, J.; Biermann-Stallwitz, J. Zugangsschwellen zu HIV-Test-Angeboten – Eine systematische Literaturanalyse [Barriers to Accessing HIV Testing Services - A Systematic Literature Review] Gesundheitswesen 2019, 81(3), E43-E57. doi:10.1055/A-0668-5621 DOI: https://doi.org/10.1055/a-0668-5621

Ramaswami, R.; Lurain, K.; Yarchoan, R. Oncologic Treatment of HIV-Associated Kaposi Sarcoma 40 Years on. J. Clin. Oncol. 2022, 40(3), 294-306. doi:10.1200/JCO.21.02040 DOI: https://doi.org/10.1200/JCO.21.02040

Arul, A.S.K.J.; Kumar, A.R.; Verma, S.; Arul, A.S.S.J. Oral Kaposi’s sarcoma: Sole presentation in HIV seropositive patient. J. Nat. Sci. Biol. Med. 2015, 6(2), 459-461. doi:10.4103/0976-9668.160041 DOI: https://doi.org/10.4103/0976-9668.160041

Szymon Barczak

szymon.barczak@gmail.com

Afiliacja:

a:1:{s:5:"en_US";s:28:"Medical University of Warsaw";} Poland

Barbara Badura

Afiliacja:

Students’ Scientific Society of the Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, 01-201 Warsaw, Poland Poland

Agnieszka Lembas

Afiliacja:

Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, 01-201 Warsaw, Poland; Warsaw’s Hospital for Infectious Diseases, 01-201 Warsaw, Poland Poland

Tomasz Mikuła

Afiliacja:

Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, 01-201 Warsaw, Poland; Warsaw’s Hospital for Infectious Diseases, 01-201 Warsaw, Poland Poland

Alicja Wiercińska-Drapało

Afiliacja:

Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, 01-201 Warsaw, Poland; Warsaw’s Hospital for Infectious Diseases, 01-201 Warsaw, Poland Poland